Literature DB >> 12609455

The ILAE/IBE/WHO Global Campaign against Epilepsy: Bringing Epilepsy "Out of the Shadows"

Edward H. Reynolds.   

Abstract

Epilepsy affects at least 100 million people worldwide at some time in their lives, especially in childhood and adolescence. It is a universal problem involving all ages, races, social classes, and nations. Nevertheless, it has been misunderstood, feared, and stigmatized for more than 3000 years. The psychosocial and economic consequences of epilepsy are considerable in developed nations but are even greater in developing nations, where the treatment gap may vary from 60 to 98%. To address the long-standing worldwide neglect of this disease, a campaign titled Epilepsy: Out of the Shadows has been launched by an alliance of three global organizations: the International League against Epilepsy (ILAE), the International Bureau for Epilepsy (IBE), and the World Health Organization (WHO). Global, regional, and national initiatives are currently underway.

Entities:  

Year:  2000        PMID: 12609455     DOI: 10.1006/ebeh.2000.0104

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  13 in total

1.  Why should modified Atkins diet be encouraged for treating epilepsy in emerging countries?

Authors:  Amal Satte; Eric Heath Kossoff; Mohamed Belghiti; Abderrahim Zerhouni; Hamid Ouhabi; Hassania Guerinech; Jamal Mounach
Journal:  Afr Health Sci       Date:  2017-06       Impact factor: 0.927

Review 2.  Global Health and Epilepsy: Update and Future Directions.

Authors:  Mary C Spiciarich; Jane R von Gaudecker; Laura Jurasek; Dave F Clarke; Jorge Burneo; Jorge Vidaurre
Journal:  Curr Neurol Neurosci Rep       Date:  2019-05-01       Impact factor: 5.081

3.  Epilepsy care in developing countries: part I of II.

Authors:  Gretchen L Birbeck
Journal:  Epilepsy Curr       Date:  2010-07       Impact factor: 7.500

4.  Underutilization of advanced presurgical studies and high rates of vagus nerve stimulation for drug-resistant epilepsy: a single-center experience and recommendations.

Authors:  Elena Solli; Nicole A Colwell; Christopher Markosian; Anmol S Johal; Rebecca Houston; M Omar Iqbal; Irene Say; Joseph I Petrsoric; Luke D Tomycz
Journal:  Acta Neurochir (Wien)       Date:  2021-11-13       Impact factor: 2.216

5.  Single-cell transcriptomics and surface epitope detection in human brain epileptic lesions identifies pro-inflammatory signaling.

Authors:  Pavanish Kumar; Amanda Lim; Sharifah Nur Hazirah; Camillus Jian Hui Chua; Adeline Ngoh; Su Li Poh; Tong Hong Yeo; Jocelyn Lim; Simon Ling; Nursyuhadah Binte Sutamam; Enrico Petretto; David Chyi Yeu Low; Li Zeng; Eng-King Tan; Thaschawee Arkachaisri; Joo Guan Yeo; Florent Ginhoux; Derrick Chan; Salvatore Albani
Journal:  Nat Neurosci       Date:  2022-06-23       Impact factor: 28.771

Review 6.  Stigma in epilepsy.

Authors:  Kirsten M Fiest; Gretchen L Birbeck; Ann Jacoby; Nathalie Jette
Journal:  Curr Neurol Neurosci Rep       Date:  2014-05       Impact factor: 5.081

7.  Next-generation sequencing improves treatment efficacy and reduces hospitalization in children with drug-resistant epilepsy.

Authors:  Jing Peng; Nan Pang; Ying Wang; Xiao-Le Wang; Jian Chen; Juan Xiong; Pan Peng; Can-Hui Zhu; Miriam Barakael Kessi; Fang He; Fei Yin
Journal:  CNS Neurosci Ther       Date:  2018-06-22       Impact factor: 5.243

Review 8.  The epilepsy treatment gap in developing countries: a systematic review of the magnitude, causes, and intervention strategies.

Authors:  Caroline K Mbuba; Anthony K Ngugi; Charles R Newton; Julie A Carter
Journal:  Epilepsia       Date:  2008-06-13       Impact factor: 5.864

9.  Packages of care for epilepsy in low- and middle-income countries.

Authors:  Caroline K Mbuba; Charles R Newton
Journal:  PLoS Med       Date:  2009-10-13       Impact factor: 11.069

10.  Caregiver burden in epilepsy: determinants and impact.

Authors:  Ioannis Karakis; Andrew J Cole; Georgia D Montouris; Marta San Luciano; Kimford J Meador; Charitomeni Piperidou
Journal:  Epilepsy Res Treat       Date:  2014-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.